Anti‐mitotic agent SB‐216 overcomes taxane resistance in castration‐resistant prostate cancer and exhibits anti‐tumour efficacy in pancreatic cancer

Rui Wang(University of Tennessee Health Science Center), Wěi Li(First Affiliated Hospital of Xi'an Jiaotong University)
British Journal of Pharmacology
December 17, 2025
Cited by 0


Related Papers